+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Digital Therapeutics Market - Global Forecast 2026-2032- Product Image
Digital Therapeutics Market - Global Forecast 2026-2032- Product Image
New

Digital Therapeutics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336451
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Digital therapeutics are reshaping the healthcare landscape, moving from experimental stages to become a core element in modern clinical protocols. As demand grows, senior decision-makers must leverage clear market intelligence and strategic insight to evaluate operational, commercial, and investment opportunities within this dynamic market.

Market Snapshot: Digital Therapeutics Market Overview

The digital therapeutics market advanced from USD 5.61 billion in 2024 to USD 6.41 billion in 2025, with projections indicating sustained growth at a CAGR of 15.72% and reaching USD 18.05 billion by 2032. This momentum stems from improved clinical validation, increased payer participation, and evolving regulatory clarity, all of which build confidence among providers and industry leaders. As adoption accelerates, the competitive landscape is shaped by product credibility, integration with existing clinical workflows, and value demonstration for stakeholders.

Scope & Segmentation of the Digital Therapeutics Market

This report delivers comprehensive coverage across a diverse set of market dimensions, enabling precise strategy formation for digital therapeutics solutions. Each segment reflects unique requirements and growth opportunities:

  • Therapeutic Domains: Analysis covers cardiovascular, diabetes, mental health, neurology, oncology, and respiratory applications, each presenting specific integration challenges and evidence needs for market acceptance.
  • Delivery Models: Assessment includes cloud-native solutions, desktop analytics, mobile applications, virtual reality therapies, and web-based interfaces, facilitating deployment in diverse clinical and organizational settings.
  • End Users: The landscape spans employers, healthcare providers including nurses, physicians, therapists, patients, and payers, with varying adoption drivers and requirements for workflow fit.
  • Applications: Insights address disease management, rehabilitation, remote monitoring, and wellness management, along with considerations for sensor integration, wearable partnerships, and interoperability in data ecosystems.
  • Distribution Channels: Evaluation includes direct, hospital, and pharmacy channels as well as company websites and app stores, addressing distinct acquisition pathways and market reach potential.
  • Pricing Models: Market review covers licensing, pay-per-use, and subscription frameworks, with examination of annual and monthly tiers that shape revenue streams and retention strategies.
  • Deployment Models: Focus is placed on cloud and on-premise deployment options, highlighting implications for procurement planning and IT resource use.
  • Geographic Focus: Regional market contexts span the Americas, Europe, Middle East & Africa, and Asia-Pacific, presenting diverse regulatory, reimbursement, and adoption landscapes.

Key Takeaways for Senior Decision-Makers

  • Digital therapeutics are now integral to hybrid care models, adding value through personalized interventions that complement traditional treatments.
  • Interoperability standards are advancing, allowing seamless integration of solutions into electronic health records and enhancing remote monitoring capabilities.
  • Commercial strategies increasingly focus on contracts tied to patient outcomes, with subscriptions and outcome-based agreements underscoring clinical and economic value.
  • User experience and clinician alignment influence both product design and overall patient adoption, reinforcing the importance of real-world feedback and user-centered innovation.
  • Payer collaboration, supported by ongoing evidence generation such as pragmatic studies and post-market reviews, is critical for maintaining access and differentiation.
  • Regional variations in regulatory and reimbursement frameworks mandate localized strategies for sustainable entry, scaling, and risk mitigation across markets.

Tariff Impact: Supply Chain and Cost Strategy in 2025

Recent tariff changes in the United States have significant implications for global supply chains in digital therapeutics, especially for products involving international hardware or wearable sensor sourcing. These developments prompt companies to reconsider supplier relationships, pursue nearshoring and domestic manufacturing, and emphasize modular product designs to manage rising costs. Such changes directly affect procurement and operational stability for remote care programs and employer-facing offerings. Tariff-driven challenges also necessitate updates in contractual arrangements, localized support, and cloud service strategies, highlighting the need for flexible and robust operational planning.

Methodology & Data Sources

The research applies a mixed-methods approach, integrating structured interviews with clinicians, payers, employers, and technology leaders, as well as targeted patient and end-user surveys. The report relies on peer-reviewed literature, regulatory documentation, and health-economic analyses to ensure reliable insights. Methodological rigor is maintained through scenario planning, thematic and quantitative analysis, and expert validation, with full transparency of tools for reproducibility.

Why This Report Matters

  • Equips executive teams with actionable intelligence to align clinical, commercial, and operational digital therapeutics strategies based on verified market trends and regional dynamics.
  • Addresses emerging risks and identifies supply chain, reimbursement, and product development opportunities amid ongoing policy and technological shifts.
  • Delivers recommendations to speed adoption and establish scalable, sustainable business models in varied healthcare markets worldwide.

Conclusion

Leaders who focus on evidence, interoperability, and resilient operations will position their organizations for success in digital therapeutics. Sustained competitiveness rests on integrating clinical, commercial, and supply chain excellence to achieve meaningful patient and business outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2024
3.5. FPNV Positioning Matrix, 2024
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Digital Therapeutics Market, by Product Type
8.1. Non-Prescription / Over-the-Counter (OTC) Digital Therapeutics
8.2. Prescription Digital Therapeutics (PDTx)
9. Digital Therapeutics Market, by Therapy Area
9.1. Diabetes Management
9.2. Neurological Disorders
9.2.1. Depression
9.2.2. Anxiety Disorders
9.2.3. Schizophrenia
9.2.4. Epilepsy
9.2.5. Multiple Sclerosis
9.3. Obesity & Weight Management
9.4. Chronic Respiratory Diseases
9.5. Cardiovascular Diseases
9.6. Mental & Behavioral Health
9.7. Musculoskeletal Disorders / Pain Management
9.8. Oncology Support Care
9.9. Gastrointestinal Disorders
9.10. Smoking Cessation
9.11. Women’s Health
9.12. Rehabilitation & Physical Therapy
9.13. Substance Use Disorders
9.14. Sleep Disorders
10. Digital Therapeutics Market, by Platform
10.1. Smartphone-Based Applications
10.2. Wearable Device-Integrated DTx
10.3. AI/ML-Based Digital Therapies
10.4. Virtual Reality (VR)-Based DTx
10.5. Digital Monitoring + Feedback Systems
10.6. Web-Based / Cross-Platform Therapeutics
11. Digital Therapeutics Market, by Channel Type
11.1. Patients / Direct-to-Consumer (D2C)
11.2. Healthcare Providers (Hospitals & Clinics)
11.3. Employers / Corporate Wellness Programs
11.4. Pharmaceutical Partnerships
11.5. Government & Public Health Systems
12. Digital Therapeutics Market, by End User
12.1. Patients
12.2. Healthcare Providers
12.3. Employers & Corporate Wellness
12.4. Caregivers & Rehabilitation Centers
13. Digital Therapeutics Market, by Deployment Mode
13.1. Cloud-Based
13.2. On-Premise
13.3. Hybrid Deployment
14. Digital Therapeutics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Digital Therapeutics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Digital Therapeutics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Digital Therapeutics Market
18. China Digital Therapeutics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2024
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2024
19.3. Product Portfolio Analysis, 2024
19.4. Benchmarking Analysis, 2024
19.5. Abbott Laboratories
19.6. F. Hoffmann-La Roche Ltd
19.7. Noom, Inc.
19.8. Novartis AG
19.9. Novo Nordisk A/S
19.10. Omada Health, Inc.
19.11. Otsuka Holdings Co., Ltd.
19.12. ResMed, Inc.
19.13. Teladoc Health, Inc.
19.14. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY NON-PRESCRIPTION / OVER-THE-COUNTER (OTC) DIGITAL THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY NON-PRESCRIPTION / OVER-THE-COUNTER (OTC) DIGITAL THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY NON-PRESCRIPTION / OVER-THE-COUNTER (OTC) DIGITAL THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRESCRIPTION DIGITAL THERAPEUTICS (PDTX), BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRESCRIPTION DIGITAL THERAPEUTICS (PDTX), BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRESCRIPTION DIGITAL THERAPEUTICS (PDTX), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPRESSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ANXIETY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ANXIETY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ANXIETY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SCHIZOPHRENIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SCHIZOPHRENIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL & BEHAVIORAL HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL & BEHAVIORAL HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL & BEHAVIORAL HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS / PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS / PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS / PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY SUPPORT CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY SUPPORT CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY SUPPORT CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WOMEN’S HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WOMEN’S HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REHABILITATION & PHYSICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REHABILITATION & PHYSICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REHABILITATION & PHYSICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SUBSTANCE USE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SUBSTANCE USE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SUBSTANCE USE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SLEEP DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SLEEP DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SLEEP DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMARTPHONE-BASED APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMARTPHONE-BASED APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMARTPHONE-BASED APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WEARABLE DEVICE-INTEGRATED DTX, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WEARABLE DEVICE-INTEGRATED DTX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WEARABLE DEVICE-INTEGRATED DTX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY AI/ML-BASED DIGITAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY AI/ML-BASED DIGITAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY AI/ML-BASED DIGITAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY VIRTUAL REALITY (VR)-BASED DTX, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY VIRTUAL REALITY (VR)-BASED DTX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY VIRTUAL REALITY (VR)-BASED DTX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIGITAL MONITORING + FEEDBACK SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIGITAL MONITORING + FEEDBACK SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIGITAL MONITORING + FEEDBACK SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WEB-BASED / CROSS-PLATFORM THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WEB-BASED / CROSS-PLATFORM THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY WEB-BASED / CROSS-PLATFORM THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENTS / DIRECT-TO-CONSUMER (D2C), BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENTS / DIRECT-TO-CONSUMER (D2C), BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENTS / DIRECT-TO-CONSUMER (D2C), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HEALTHCARE PROVIDERS (HOSPITALS & CLINICS), BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HEALTHCARE PROVIDERS (HOSPITALS & CLINICS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HEALTHCARE PROVIDERS (HOSPITALS & CLINICS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYERS / CORPORATE WELLNESS PROGRAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYERS / CORPORATE WELLNESS PROGRAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYERS / CORPORATE WELLNESS PROGRAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL PARTNERSHIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL PARTNERSHIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL PARTNERSHIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYERS & CORPORATE WELLNESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYERS & CORPORATE WELLNESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYERS & CORPORATE WELLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CAREGIVERS & REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CAREGIVERS & REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CAREGIVERS & REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HYBRID DEPLOYMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HYBRID DEPLOYMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY HYBRID DEPLOYMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 162. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 164. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 165. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 175. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 178. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 179. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 180. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 181. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 195. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 196. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 197. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 198. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 200. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 202. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 203. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 204. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 205. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 206. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 216. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 219. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 220. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 221. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 222. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 224. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 227. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 228. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 229. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 230. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 232. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 234. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 235. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 236. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 237. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 238. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 249. CHINA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 250. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 252. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 253. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 254. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 255. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Digital Therapeutics market report include:
  • 2morrow Inc.
  • Abbott Laboratories
  • AptarGroup, Inc.
  • Big Health, Inc.
  • Biofourmis Inc.
  • Canary Health Technologies Inc.
  • Click Therapeutics, Inc.
  • CogniFit Inc.
  • Cognoa, Inc.
  • CureApp, Inc.
  • DarioHealth Corp.
  • F. Hoffmann-La Roche Ltd
  • Fitterfly Healthtech Private Limited by PB Healthcare Services Pvt. Ltd.
  • GAIA AG by Ethypharm SAS
  • Glooko, Inc.
  • Grünenthal GmbH
  • H2O Therapeutics Co.
  • Headspace Inc.
  • Hinge Health, Inc.
  • Hyfe, Inc.
  • Kaia Health Software Inc.
  • Lark Technologies, Inc.
  • LifeScan, Inc.
  • Lumanity Inc.
  • Lumos Labs
  • MedRhythms
  • Noom, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Omada Health, Inc.
  • Otsuka Holdings Co., Ltd.
  • ResMed, Inc.
  • SilverCloud by American Well Corporation
  • Teladoc Health, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vida Health, Inc.
  • Virtual Therapeutics Corp.
  • Welldoc, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2025 - 2032
Estimated Market Value ( USD ) in 2025 $ 6.41 Billion
Forecasted Market Value ( USD ) by 2032 $ 18.05 Billion
Compound Annual Growth Rate15.7%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

Digital Therapeutics Market (By Component, Application, End User, Region), Company Profiles, Recent Developments, Market Dynamics - Growth Trends and Forecast (2025-2032) - Product Image

Digital Therapeutics Market (By Component, Application, End User, Region), Company Profiles, Recent Developments, Market Dynamics - Growth Trends and Forecast (2025-2032)

  • Report
  • 105 Pages
  • Global
From
Digital Therapeutic Devices Market - Global Forecast 2026-2032 - Product Image

Digital Therapeutic Devices Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Digital Health Market - Global Forecast 2026-2030 - Product Image

Digital Health Market - Global Forecast 2026-2030

  • Report
  • 199 Pages
  • Global
From
Digital Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Digital Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Digital Therapeutics Market Report and Forecast 2025-2034 - Product Image

Digital Therapeutics Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.